ClinConnect ClinConnect Logo
Search / Trial NCT04707001

Urinary Retention After Arthroplasty

Launched by CENTRAL FINLAND HOSPITAL DISTRICT · Jan 11, 2021

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is looking at how we can safely monitor when patients start to urinate on their own after having knee replacement surgery, also known as arthroplasty. After this type of surgery, some patients may have trouble urinating, which can lead to the need for a catheter (a tube placed in the bladder). The study aims to see if we can rely on patients’ symptoms alone, rather than using an ultrasound machine to check for urine in the bladder, to determine when they can urinate without help.

To participate in this trial, you would need to be scheduled for a total knee replacement surgery and be between the ages of 65 and 74. However, if you have had previous surgery for bladder cancer, are having surgery due to a fracture, or have other specific conditions that affect your urinary system, you may not be eligible. If you join the study, you can expect to be monitored closely after your surgery to see if you can urinate independently based on your symptoms. This research is important because it could help reduce the use of catheters, which can lead to infections and other complications.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • elective total knee arthroplasty
  • Exclusion Criteria:
  • previous surgery for urologic cancer
  • fracture as indication for surgery
  • lack of co-operation
  • untreated urinary retention
  • nephrostoma
  • general anesthesia

About Central Finland Hospital District

Central Finland Hospital District is a leading healthcare organization dedicated to advancing medical research and improving patient care through innovative clinical trials. Committed to the highest standards of ethical practice and scientific rigor, the district collaborates with a network of healthcare professionals and researchers to facilitate cutting-edge studies across various medical fields. With a focus on enhancing treatment outcomes and fostering health advancements, Central Finland Hospital District plays a pivotal role in translating research findings into practical applications that benefit the community and beyond.

Locations

Jyväskylä, , Finland

Patients applied

0 patients applied

Trial Officials

Juha Paloneva, professor

Principal Investigator

Chief medical director

Heikki Seikkula, PhD

Study Chair

Investigator

Juho Sippola, MD

Study Chair

Investigator

Konsta Pamilo, PhD

Study Chair

Investigator

Jonne Åkerla, MD

Study Chair

Investigator

Aleksi Reito, PhD

Study Chair

Investigator

Pirkko Kinnunen

Study Chair

Investigator

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials